Analysts are offering their insights and perspectives on financial companies including BayCom (BCML), Stifel Financial (SF), and Northern (NTRS).

Stifel maintains a bullish outlook on ServiceNow (NOW) as the company works to rebuild its backlog after a strong performance at the end of the year.

Inhibrx shares gained value after Stifel analysts issued a new 'Buy' rating for the company, based on the performance of its lead assets.

Investment firms Stifel and Jefferies have both raised their price targets for Tango Therapeutics (TNGX) stock, signaling positive outlooks for the company.

Stifel reiterates its 'Buy' rating for Salesforce (CRM) stock after holding meetings with the company's executives, indicating continued confidence in its performance.

Stifel analysts suggest that Norwegian's conservative financial guidance should not deter investors.

Stifel has reiterated its 'Hold' rating on Revvity (RVTY), indicating a neutral stance on the company's stock performance for investors.

A court has upheld a $133 million award issued by the Financial Industry Regulatory Authority (FINRA) against Stifel.

Investment firm Stifel has upgraded an auto services stock to "buy" from "hold," asserting that investor worries regarding higher oil prices are exaggerated.

Following its fourth-quarter earnings report, Figma (FIG) has seen its price targets lowered by analysts at Stifel and Morgan Stanley.

Lumentum shares surged after the company announced a long-term quarterly revenue run rate of $2 billion at the OFC conference, according to Stifel.

Stifel analysts report on the partnership between Marvell and Mojo Vision, suggesting it will intensify competition in the micro-LED optics market.

Several financial firms have updated their ratings and price targets for a range of companies, including WesBanco, Bank OZK, LyondellBasell, W. P. Carey, Citizens Financial, Enbridge, Realty Income, Dominion Energy, Prudential Financial, Best Buy, Campbell's, Global Partners, Innovative Industrial Properties, and National Storage Affiliates, reflecting new coverage, earnings reviews, and market outlooks.

Stifel and Bernstein have reiterated their bullish ratings on Datadog, Inc. (DDOG) following the company's recent Investor Day event.

Stifel has reduced its target price on DNOW Inc. (DNOW) to $16, citing risks associated with its ERP system.

Rivian (RIVN) announced its Q4 2025 results, showcasing strong pre-production performance for its R2 model, prompting Stifel to raise its price target.

Stifel has identified supply constraints within Microsoft Corporation's Azure cloud computing division as a significant headwind for its near-term growth.

Several financial institutions have updated their price targets for a range of companies, including CytomX Therapeutics, Upwork, Coursera, Tripadvisor, and The Wendy's Company, while maintaining various ratings.

Stifel has downgraded Allied Gold Corporation (AAUC) to a 'Hold' rating, setting a C$44 price target for the company's stock.

Stifel provides its opinion on the buyout offer price for Papa John’s International Inc (PZZA), evaluating the proposed valuation.

Stifel has set a $250 price target for Texas Instruments, leading to discussions among investors about the potential for growth for the semiconductor giant.

Stifel has lowered its price target for Medtronic (MDT) to $95, attributing the adjustment to the anticipated effects of the MiniMed IPO.

Stifel has adopted a more cautious outlook on ServiceNow, even while maintaining its buy rating for the company's stock.

Stifel has reduced its price target for ServiceNow, citing concerns over weaker federal spending as the primary reason for the adjustment.

Stifel has raised its price target for Insmed Incorporated (INSM) from $205 to $208, outlining the reasons for the adjustment.

Stifel has lowered its price target on Builders FirstSource (BLDR), indicating a revised outlook for the company's stock performance.

Stifel has highlighted Marvell Technology's collaboration with Mojo Vision on optical interconnects, signaling a significant development in the tech sector.

Stifel has increased its price target for Cohu (COHU) stock to $34, indicating a more optimistic valuation.

Stifel has downgraded its rating on The Trade Desk following an audit by Publicis that revealed a breach of their agreement.

Stifel has adjusted its price target for Carnival Corporation & plc (CCL) downwards while reiterating a 'Buy' rating on the cruise line company's stock.

Stifel has increased its price target for VSE Corporation (VSEC) to $260, while reiterating a 'Buy' rating on the stock.

Stifel analysts continue to hold a bullish stance on Gildan Activewear (GIL) stock.

Stifel has raised its price target for Chatham Lodging from $8.75 to $10.

Cadence Design Systems, Inc. (CDNS) reported Q4 results that surpassed both revenue and EPS expectations, leading Stifel to reaffirm its 'Buy' rating.

Multiple financial institutions have updated their ratings and price targets for various companies, including Wells Fargo raising Globe Life (GL) target, Bank of America downgrading Fox (FOX), KeyBanc raising Zoom (ZM) target, H.C. Wainwright raising United Therapeutics (UTHR) target, Bernstein upgrading Newmont (NEM), analysts maintaining a hold on PepsiCo (PEP), Truist raising BILL Holdings (BILL) target, Barclays reiterating a buy on Charles Schwab (SCHW), Barclays upgrading Etsy (ETSY) and Truist raising its target, Goldman Sachs cutting Pinterest (PINS) target and RBC downgrading shares, Wells Fargo maintaining a hold on Hewlett Packard Enterprise (HPE), UBS upgrading Southwest Airlines (LUV), Stifel raising Triple Flag Precious Metals (TFPM) target, Barclays raising Phillips 66 (PSX) target, and Veritas downgrading Suncor Energy (SU).

Citi and Stifel maintain a bullish outlook on Olema (OLMA) even after the departure of its Chief Operating Officer.

Stifel analysts believe that the recent decline in Fulcrum Therapeutics' stock price is 'overdone,' suggesting an overreaction by the market.

Several travel and leisure companies, including Lindblad Expeditions, MakeMyTrip, Royal Caribbean, Travel + Leisure, Norwegian Cruise Line, Expedia, and Booking Holdings, have received updated price targets and ratings from various financial analysts.

EssilorLuxottica Logs Worst Week In Nearly Four Years As Apple Eyes AI Smart Glasses Shares of EssilorLuxottica SA are on track for their worst weekly decline in nearly four years, as competition in the smart-glasses market intensified this week following reports that Apple plans to launch AI-powered smart glasses in 2027. EssilorLuxottica manufactures the smart glasses that Meta sells under the Ray-Ban partnership. These glasses are in the sub-$500 category, which proves that affordability wins. Meta nailed that sweet spot in pricing, while Tim Cook's $3,500 Vision Pro has been an epic bust and failed to achieve mass adoption. It's not just Apple. Citigroup analyst Veronika Dubajova noted this week that her team "expects a number of competitive launches in the smart eyewear market over the next 12 to 24 months." Bloomberg-tracked Wall Street analyst ratings show no meaningful wave of downgrades following this week's Apple news, with roughly 93% of covering analysts maintaining a "Buy" recommendation. Stifel analyst Cedric Rossi said that the entry of Apple and Google into the smart-glasses market represents more of a catalyst than a threat. "Their presence should accelerate consumer awareness and expand the total addressable market," he told clients earlier this week, adding that EssilorLuxottica "retains several key competitive advantages." Shares of EssilorLuxottica in Paris are down about 10% this week, marking their largest weekly decline since the first week of March 2022. From the 2025 peak, shares are down 26%. Goldman analyst Jerry Shen recently published a detailed view of the AI and AR glasses supply chain, breaking it down by the companies that supply the critical components behind these devices (see report). Tim Cook blew it with Vision Pro ... Meta takes the win. Apple has to focus on affordability ... Tyler Durden Fri, 02/20/2026 - 08:20

Several tech companies, including Micron, Palo Alto Networks, Marvell, and Cloudflare, are drawing investor and analyst attention due to upcoming earnings reports, specific market dynamics like DRAM shortages, and recent business developments.

Citi has cut its target for Medtronic (MDT), while Stifel has lowered its outlook for the company, following the recent MiniMed IPO.

Investment firm Stifel has upgraded a semiconductor maker to a 'buy' rating from 'hold', citing the ongoing boom in AI data center development as a key growth driver.

Stifel analysts are evaluating Viridian's prospects for market differentiation following the release of new data from Amgen, suggesting a potential path forward for the company.

Stifel has reiterated its 'Buy' rating for Hillman Solutions Corp., citing a positive outlook after the company's inaugural Investor Day event.

Stifel has reiterated its 'Hold' rating on Lucid (LCID) shares following the company's recent Investor Day event.

Stifel announced a 12% growth in client assets and projected a significant 30%-40% surge in its Q1 investment banking revenue.

Nkarta has filed a $350 million shelf offering and announced plans for a $100 million at-the-market (ATM) stock sale through Stifel.

Intuitive Machines (LUNR) shares surged by 13.9% after Stifel upgraded its price target for the company.

Stifel has upgraded its rating for Ichor Holdings (ICHR) stock from 'Hold' to 'Buy', indicating increased confidence in its performance.

Coherent's stock climbed after the company reinforced its critical position in the build-out of AI data centers during the OFC conference, according to Stifel.

Stifel has reportedly lowered its price target for Oracle Corporation (ORCL), signaling a revised outlook for the technology company's stock performance.

Stifel has lowered its price target on Eos Energy Enterprises, Inc. (EOSE) while maintaining a Buy rating on the stock.

Melius Research and Stifel have both downgraded Microsoft Corporation's stock rating to 'Hold', signaling a more cautious outlook on the tech giant.

Stifel has lowered its price target for Docebo to $28 from $34.

Stifel has reduced its price target for Credo (CRDO), even as the company engages in a collaboration with Tensorwave on AI infrastructure, indicating a cautious outlook.

Several companies, including Oneok, Workday, Clearway Energy, MongoDB, Ferguson, and Kiniksa, have received updated price targets from various financial institutions.

Stifel predicts that the ongoing shift of investments from growth stocks to value names could negatively impact overall S&P 500 returns in the long term.

Several financial firms have raised their price targets for individual companies, including Diebold Nixdorf, SharkNinja, The Williams Companies, and FedEx, indicating positive outlooks for these stocks.

Stifel views the current downtime as an opportune moment for investors to acquire shares in Hinge Health, Inc.

Several financial institutions, including Stifel, Scotiabank, and Jefferies, have issued updated price targets and ratings for various companies. These reports reflect analysts' current outlooks on stock performance and investment recommendations.